Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Jan 7, 2009; 15(1): 95-101
Published online Jan 7, 2009. doi: 10.3748/wjg.15.95
Published online Jan 7, 2009. doi: 10.3748/wjg.15.95
Figure 4 Enzymatic histochemistry staining of endogenous β-G (cryostat section,× 400) in CPC group (A) and c-myc shRNA-3 treatment group (B).
A notable reduction of endogenous β-G was observed in the bile duct wall following c-myc shRNA treatment.
- Citation: Li FY, Cheng NS, Cheng JQ, Mao H, Jiang LS, Li N, He S. Treatment of chronic proliferative cholangitis with c-myc shRNA . World J Gastroenterol 2009; 15(1): 95-101
- URL: https://www.wjgnet.com/1007-9327/full/v15/i1/95.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.95